# Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia

> **NCT02088983** · PHASE2 · UNKNOWN · sponsor: **University of Ottawa** · enrollment: 40 (estimated)

## Conditions studied

- First Episode Schizophrenia

## Interventions

- **DIETARY_SUPPLEMENT:** CDP-Choline
- **DIETARY_SUPPLEMENT:** Cellulose

## Key facts

- **NCT ID:** NCT02088983
- **Lead sponsor:** University of Ottawa
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2015-04
- **Final completion:** 2016-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02088983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02088983, "Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02088983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*